✦ LIBER ✦

Oxygen isosteric derivatives of 3-(3-hydroxyphenyl)-N-n-propylpiperidine

✍ Scribed by Perrone, Roberto; Berardi, Francesco; Leopoldo, Marcello; Tortorella, Vincenzo; Lograno, Marcello D.; Daniele, Eugenia; Govoni, Stefano

Book ID: 127113533
Publisher: American Chemical Society
Year: 1992
Tongue: English
Weight: 739 KB
Volume: 35
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm00094a019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2,5-Dimethoxy congeners of (+)- and (-)-

2,5-Dimethoxy congeners of (+)- and (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine

✍ Cannon, Joseph G.; Kirschbaum, Karen S.; Amoo, Victor E. D.; Johnson, Alan K.; L 📂 Article 📅 1993 🏛 American Chemical Society 🌐 English ⚖ 533 KB

Resolved 3-(3-Hydroxyphenyl)-N-n-propylp

Resolved 3-(3-Hydroxyphenyl)-N-n-propylpiperidine and its analogs: central dopamine receptor activity

✍ Wikstroem, Haakan; Sanchez, Domingo; Lindberg, Per; Hacksell, Uli; Arvidsson, La 📂 Article 📅 1984 🏛 American Chemical Society 🌐 English ⚖ 953 KB

Carbamate ester derivatives as potential

Carbamate ester derivatives as potential prodrugs of the presynaptic dopamine autoreceptor agonist (-)-3-(3-hydroxyphenyl)-N-propylpiperidine

✍ Thorberg, Seth Olov; Berg, Stefan; Lundstroem, Jan; Pettersson, Bodil; Wijkstroe 📂 Article 📅 1987 🏛 American Chemical Society 🌐 English ⚖ 684 KB

Antipsychotic Properties of the Partial

Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia

✍ Adrienne C Lahti; Martin A Weiler; Patricia K Corey; Robert A Lahti; Arvid Carls 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Differential effects of the enantiomers

Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptors sites

✍ Susan W. Koch; B.Kenneth Koe; Nicholas G. Bacopoulos 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 334 KB

Motor effects of the partial dopamine ag

Motor effects of the partial dopamine agonist (−)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in Parkinson's disease

✍ L. Verhagen Metman; V. H. Sethy; J. R. Roberts; D. Bravi; J. I. Hoff; M. M. Mour 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

## Abstract The motor effects of the partial dopamine agonist (–)‐3‐(3‐hydroxyphenyl)‐N‐n‐propylpiperidine [(–)‐3‐PPP, preclamol] were evaluated in nine patients with Parkinson's disease using a double‐blind, placebocontrolled design. (–)‐3‐PPP monotherapy had an antiparkinsonian effect in five of